Identification
Personal identification
- Full name
- Helena Isabel Fialho Florindo Roque Ferreira
- Date of birth
- 1979/08/17
- Gender
- Female
Citation names
- Ferreira, Helena
- Helena F Florindo
- Helena Florindo
Author identifiers
- Ciência ID
- C512-A1B0-BE82
- ORCID iD
- 0000-0002-4006-5840
- Google Scholar ID
- https://scholar.google.com/citations?user=3FL_2sQAAAAJ&hl=en
- Researcher Id
- E-7913-2012
- Scopus Author Id
- 24402599300
Email addresses
- hflorindo@ff.ulisboa.pt (Professional)
- hflorindo@ff.ul.pt (Professional)
- helena.florindo@gmail.com (Personal)
Addresses
- Faculdade de Farmácia Universidade de Lisboa, Instituto de Investigação do Medicamento (iMed.ULisboa) . Faculdade de Farmácia Universidade de Lisboa, Av Prof Gama Pinto, Edifício E , 1649-003, Lisboa, Lisboa, Portugal (Professional)
Websites
- https://imed.ulisboa.pt/labs/helena-florindo-lab/ (Professional)
Knowledge fields
- Engineering and Technology - Nano-technology
- Medical and Health Sciences - Health Sciences
- Medical and Health Sciences - Basic Medicine - Pharmacology and pharmacy
- Medical and Health Sciences - Basic Medicine - Immunology
- Medical and Health Sciences - Health Sciences - Infectious Diseases
Languages
Language | Speaking | Reading | Writing | Listening | Peer-review |
---|---|---|---|---|---|
English | Advanced (C1) | Advanced (C1) | Advanced (C1) | Advanced (C1) | |
Spanish; Castilian | Intermediate (B1) | Intermediate (B1) | Beginner (A1) | Intermediate (B1) | |
French | Beginner (A1) | Intermediate (B1) | Beginner (A1) | Beginner (A1) |
Education
Degree | Classification | |
---|---|---|
2018
Concluded
|
NA (Título de Agregado)
Universidade de Lisboa Faculdade de Farmácia, Portugal
"NA" (THESIS/DISSERTATION)
|
Approved |
2008
Concluded
|
Pharmaceutical Sciences (Doutoramento)
Universidade de Lisboa Faculdade de Farmácia, Portugal
"Development of alternative micro and nanoparticulate polymeric systems for mucosal delivery of Streptococcus equi antigens" (THESIS/DISSERTATION)
|
Pass with Distinction and Honors |
2008
Concluded
|
Farmácia (Doutoramento)
Major in Especialidade: Tecnologia Farmacêutica
Universidade de Lisboa, Portugal
"Development of Alternative Micro and Nanoparticulate Polymeric Systems for Mucosal Delivery of Streptococcus Equi Antigens" (THESIS/DISSERTATION)
|
|
2003
Concluded
|
Pharmaceutical Sciences (Licenciatura)
Universidade de Lisboa Faculdade de Farmácia, Portugal
"na" (THESIS/DISSERTATION)
|
16/20 valores |
Affiliation
Science
Category Host institution |
Employer | |
---|---|---|
2007/07/01 - Current | Researcher (Research) | Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal |
Universidade de Lisboa Faculdade de Farmácia, Portugal |
Teaching in Higher Education
Category Host institution |
Employer | |
---|---|---|
2023/08/28 - Current | Full Professor (University Teacher) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
Universidade de Lisboa Faculdade de Farmácia, Portugal | ||
2020/09/10 - 2023/08/27 | Associate Professor (University Teacher) | Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal |
Universidade de Lisboa Faculdade de Farmácia, Portugal | ||
2015/11/27 - 2018/02/01 | Assistant Professor (University Teacher) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2014 - 2015 | Assistant Professor (University Teacher) | Universidade de Coimbra Faculdade de Farmácia, Portugal |
2008/11/26 - 2013/11/26 | Assistant Professor (University Teacher) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2008 - 2013 | Assistant Professor (University Teacher) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2008/07/26 - 2008/11/25 | Assistant (University Teacher) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2005/09/19 - 2008/09/26 | Trainee Assistant (University Teacher) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
Positions / Appointments
Category Host institution |
Employer | |
---|---|---|
2023/07/01 - Current | Chair | Controlled Release Society - Nanomedicine and Nanoscale Delivery Focus Group , United States |
2022/01/29 - Current | President | Spanish-Portuguese Local Chapter - Controlled Release Society, Portugal |
2020/02/01 - Current | Manager of Laboratory, Institute, Museum, Centre or Observatory | Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal |
Universidade de Lisboa Faculdade de Farmácia, Portugal | ||
2016/12/01 - Current | Member of the Portuguese Medicines Evaluation Board (CAM) | Infarmed Autoridade Nacional do Medicamento e Produtos de Saúde IP, Portugal |
2014/01/02 - Current | Board Member of the Non-teaching staff Evaluation Board (SIADAP) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
Universidade de Lisboa Faculdade de Farmácia, Portugal | ||
2020/09/05 - 2023/08/27 | Associate Professor with Habilitation | Universidade de Lisboa Faculdade de Farmácia, Portugal |
Universidade de Lisboa Faculdade de Farmácia, Portugal | ||
2021/08/01 - 2023/06/30 | Co-Chair | Controlled Release Society - Nanomedicine and Nanoscale Delivery Focus Group , United States |
2020/01/22 - 2022/01/21 | Board Member - Vice-secretary | Spanish-Portuguese Local Chapter - Controlled Release Society, Portugal |
Universidade de Lisboa Faculdade de Farmácia, Portugal | ||
2018/02/02 - 2020/09/30 | Assistant Professor with Habilitation | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2019/07/28 - 2020/07/27 | Secretary Treasurer | Controlled Release Society - Nanomedicine and Nanoscale Delivery Focus Group , United States |
Universidade de Lisboa Faculdade de Farmácia, Portugal |
Others
Category Host institution |
Employer | |
---|---|---|
2015/01/01 - Current | <b>Group leader</b> of the BioNanoSciences ¿ Drug Delivery & Immunoengineering research group | Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal |
2008/11/26 - 2018/01/31 | <b>Assistant Professor of Pharmaceutics</b> <b>Coordinator of Pharmaceutical Technology III in Pharmaceutical Sciences Master </b>(since 2013/2014); <b>Maternity leave</b> (5 months, December 2009/M | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2003/10/01 - 2007/10/01 | <b>PhD student </b>awarded with a FCT grant PhD fellowship POCI 2010 SFRH/BD/14370/2003 | Universidade de Lisboa Faculdade de Farmácia, Portugal |
Projects
Grant
Designation | Funders | |
---|---|---|
2022/12/01 - Current | Multifunctional nano-immunotherapy against breast brain metastases
LCF/PR/HR22/52420016
PTDC/BTM-SAL/4350/2021
Principal investigator
“La Caixa” Banking Foundation, Spain
Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento, Portugal |
“La Caixa” Banking Foundation Fundação para a Ciência e a Tecnologia, I.P. Ongoing
|
2020/08/10 - Current | Development of a translational COVID-19 Vaccine
LCF/TR/CD20/52700005
Principal investigator
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
“La Caixa” Banking Foundation
Ongoing
|
2025 - 2027 | Precision ImmuneNanoTherapy targeting tumor-immune-stroma interactions against pancreatic cancer
LCF/PR/HR24/00968
|
Fundación Bancaria Caixa d’Estalvis i Pensions de Barcelona |
2021/01/01 - 2024/01/01 | Biomimetic cell membrane-coated vitamin E-based micelles for multimodal pancreatic cancer nanotheranostics
PTDC/BTM-MAT/4738/2020
PTDC/BTM-MAT/4738/2020
Universidade Nova de Lisboa, Portugal
Rede de Química e Tecnologia Laboratório Associado para a Química Verde, Portugal University of Strathclyde, United Kingdom Universidade de Coimbra, Portugal Universidade de Santiago de Compostela, Spain |
Fundação para a Ciência e a Tecnologia
Ongoing
|
2022/01/01 - 2023/07/05 | Next-generation nanomaterials to sensitize breast cancer to immunotherapy
UTAP-EXPL/NPN/0041/2021
Principal investigator
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
Fundação para a Ciência e a Tecnologia, I.P.
Ongoing
|
2020/10/01 - 2021/09/30 | Nanomaterials to design new vaccine adjuvants
UTA-EXPL/NPN/0082/2019
Co-Principal Investigator
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
Fundação para a Ciência e a Tecnologia, I.P.
Ongoing
|
2015/06 - 2018/06 | Multidisciplinary strategy to develop novel multicomponent nanoscale systems for immune modulation
UTAP-ICDT/DTP-FTO/0016/2014
|
Ministério da Ciência, Tecnologia e Inovação |
2012/03 - 2015/03 | TherMelVac- dendritic cell-targeted peptide vaccine against melanoma by ligand-modified nanoparticles | Fundação para a Ciência e a Tecnologia, I.P. |
2012/02 - 2015/02 | siRNA incorporation in a lipid/micelle-based nanocarrier as a strategy to restore E-cadherin expression and eradicate advanced breast cancer metastatic phenotype | Fundação para a Ciência e a Tecnologia, I.P. |
2011/01 - 2014/06 | Pre-clinical assays of a GAPDH-based vaccine against Group B Streptococcus infection | Fundação para a Ciência e a Tecnologia, I.P. |
2010/01 - 2012/12 | Targeting combined therapy to cancer stem cells | Fundação para a Ciência e a Tecnologia, I.P. |
2007/09 - 2012/03 | Integrated methodologies for the development of bi and three-valent DNA-vaccines against Helycobacter pylori | Fundação para a Ciência e a Tecnologia, I.P. |
2007/01 - 2008/04 | New approach on the development of an efficient vaccine against streptococcal infection by modulating the conditions of expression, production, purification and formulation | Fundação para a Ciência e a Tecnologia, I.P. |
Contract
Designation | Funders | |
---|---|---|
2019/11/01 - Current | NanoPanTher - Sensitizing pancreatic cancer to immunotherapy with multimodal precision nanomedicines | |
2023/03/12 - 2024/09/11 | Nano-imunoterapia para regular o perfil imunológico e o microbioma no cancro pancreático
2022.04506.PTDC
Centro de Investigación Príncipe Felipe, Spain
Universidade Nova de Lisboa Medical School, Portugal |
Fundação para a Ciência e a Tecnologia
Ongoing
|
2023/01/01 - 2024/02/29 | Development and evaluation of an mRNA vaccine against HIV-1 and HIV-2
Egas Moniz - Cooperativa de Ensino Superior Crl, Portugal
|
Gilead Sciences Lda
Concluded
|
2022 - 2023 | New opportunities for small molecules in immuno-oncology
EXPL/MED-QUI/1316/2021
Instituto Português de Oncologia de Lisboa Francisco Gentil EPE, Portugal
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal |
Fundação para a Ciência e a Tecnologia
Concluded
|
2019/11/01 - 2022/10/31 | Sensitizing pancreatic cancer to immunotherapy with multimodal precision nanomedicines
LCF/PR/HR19/52160021
Principal investigator
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
“La Caixa” Banking Foundation
Ongoing
|
2017/01/01 - 2021/06/30 | PRECISION ONCOLOGY BY INNOVATIVE THERAPIES AND TECHNOLOGIES
SAICTPAC/0019/2015
Instituto Politécnico de Leiria, Portugal
Universidade de Coimbra, Portugal Associação do Instituto Superior Técnico para a Investigação e Desenvolvimento, Portugal Universidade de Lisboa Faculdade de Medicina Veterinária, Portugal INESC Microsistemas e Nanotecnologias, Portugal Universidade de Lisboa Faculdade de Farmácia, Portugal |
Fundação para a Ciência e a Tecnologia
Ongoing
|
2018/05/01 - 2019/12/31 | POINT4PAC – Precision Oncology by Innovative Therapies and Technologies
SAICTPAC/0019/2015
|
|
2017/01 - 2019/12 | MultiNano@MBM: Modulation of melanoma-stroma interactions using a rationally-designed nanomedicine combining BRAFi-, MEKi-
and immune-therapies
ENMed/0051/2016
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
Secretaria de Estado de Ciência Tecnologia e Ensino Superior Fundação para a Ciência e a Tecnologia Concluded
|
2016/01/01 - 2019 | NanoTumin – Targeting tumor microenvironment by a translational multivalent nanomedicine: towards an effective anticancer
combination immunotherapy
ENMed/0003/2015
|
|
2012/02/02 - 2015/09/30 | Nanopartículas lípidicas/micelares para encapsulamento de siRNA como estratégia para recuperar a expressaõ de E-cadherina
e suprimir o fenótipo tumorogénico do tumor da mama avançado
PTDC/SAU-FAR/120453/2010
Universidade de Coimbra, Portugal
Institut d'Investigació Biomèdica de Bellvitge, Spain Universidade de Lisboa Faculdade de Farmácia, Portugal |
Fundação para a Ciência e a Tecnologia
Concluded
|
2011/01/01 - 2014/06/30 | Ensaios pré-clinicos com a vacina constituida pela GAPDH de Streptococcus agalactiae
PTDC/SAU-MIC/111387/2009
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
Universidade do Porto Instituto de Ciências Tecnologias e Agroambiente, Portugal Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal Universidade de Lisboa Faculdade de Farmácia, Portugal |
Fundação para a Ciência e a Tecnologia
Concluded
|
2011/01/01 - 2013/12/31 | Projecto Estratégico - UI 4013 - 2011-2012
PEst-OE/SAU/UI4013/2011
PEst-OE/EQB/LA0004/2011
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica António Xavier, Portugal
Universidade Nova de Lisboa Medical School, Portugal Instituto de Biologia Experimental e Tecnológica, Portugal Centro de Estudos de Recursos Naturais Ambiente e Sociedade, Portugal Universidade de Trás-os-Montes e Alto Douro Centro de Investigação e de Tecnologias Agro-Ambientais e Biologicas, Portugal |
Fundação para a Ciência e a Tecnologia
Concluded
|
2007/09/01 - 2012/03/31 | Metodologias integradas para o desenvolvimento de vacinas de DNA bi- e tri-valentes contra o Helycobacter pylori
PTDC/BIO/69242/2006
Universidade Católica Portuguesa Campus Sintra, Portugal
Hospital do Espírito Santo de Évora EPE, Portugal Universidade Católica Portuguesa, Portugal Universidade de Lisboa Faculdade de Farmácia, Portugal |
Fundação para a Ciência e a Tecnologia
Concluded
|
2005/01/01 - 2006/12/31 | Nova abordagem do desenvolvimento de uma vacina anti-spreptococica através da modulação das condições de expressão, produção,
purificação e formulação
POCI/BIO/59147/2004
Instituto de Biologia Experimental e Tecnológica, Portugal
Universidade de Lisboa Faculdade de Farmácia, Portugal |
Fundação para a Ciência e a Tecnologia
Concluded
|
Other
Designation | Funders | |
---|---|---|
2020/03/01 - Current | The use of co-creation to overcome medication adherence barriers experienced by women with breast cancer according to the
treatment phase
.
Instituto Português de Oncologia de Lisboa Francisco Gentil EPE, Portugal
Universidade de Lisboa Faculdade de Farmácia, Portugal |
Ongoing
|
Outputs
Publications
Book |
|
Book chapter |
|
Conference abstract |
|
Conference paper |
|
Conference poster |
|
Journal article |
|
Preprint |
|
Thesis / Dissertation |
|
Intellectual property
Patent |
|
Provisional application for patent |
|
Other
Other output |
|
Activities
Supervision
Thesis Title Role |
Degree Subject (Type) Institution / Organization |
|
---|---|---|
2020/02/01 - Current | Viral Envelopes Coating HPMA-Selenium Nanoparticles for Cancer Targeting Therapy
Supervisor of Cláudio Ferro
|
PhD Programme in Medicines and Pharmaceutical Innovation (i3DU) (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2019/11/12 - Current | Alteração da estratégia de controlo de qualidade de medicamentos para real-time release
Supervisor of Tânia Freire
|
M.Sc. in Pharmaceutical Engineering (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2019/11/01 - Current | Using co-creation to identify technology-based solutions to improve medication adherence against breast cancer
Co-supervisor of Catarina Bernardo
|
PhD Programme in Medicines and Pharmaceutical Innovation (i3DU) (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2019/09/01 - Current | Small molecules for cancer immunotherapy: A melanoma approach
Supervisor of Lara Serronha
|
M.Sc. in BioPharmaceutical Sciences (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2019/09/01 - Current | Combination immunotherapy against Pancreatic Cancer
Supervisor of Inês Vilar
|
M.Sc. in BioPharmaceutical Sciences (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2019/09/01 - Current | Nano-delivery approach for targeting type 1 collagen in breast cancer microenvironment
Supervisor of Mafalda Verdial
|
M.Sc. in BioPharmaceutical Sciences (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2019/09/01 - Current | Nano-vaccine combined with nano-based delivery of siRNA targeting GLUT-1 and miRNA-143 for the treatment of colorectal cancer
Supervisor of Raquel Coelho
|
M.Sc. in BioPharmaceutical Sciences (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2018/12/01 - Current | Modulation of tumor microenvironment using nanovaccine
Supervisor of Madalena Alves
|
M.Sc. in BioPharmaceutical Sciences (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2015 - 2020/04/30 | COMBI_CRC: Combinatorial multivalent nanoplatform for colorectal cancer treatment
Supervisor of Ana Isabel Neves de Matos
|
Engenharia Biomédica (PhD)
Universidade de Lisboa Instituto Superior Técnico, Portugal
|
2018/09/01 - 2019/12/12 | Multifunctional nano-vaccines against melanoma
Supervisor of Ana Filipa Gonçalves
|
M.Sc. in BioPharmaceutical Sciences (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2018/09/01 - 2019/12/01 | Impact of the Modulation of Tumor Vasculature on Cancer Vaccine Efficacy
Supervisor of Sandra Pena
|
M.Sc. in BioPharmaceutical Sciences (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2018/09/01 - 2019/12/01 | Combinational vaccines against colorectal cancer
Supervisor of Mariana Mateus
|
M.Sc. in BioPharmaceutical Sciences (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2016 - 2019/12 | Discovery and Development of Novel Small-Molecule Immune System Modulators
Co-supervisor of Ana Rita de Carvalho Acúrcio
|
Farmácia (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2019 - 2019 | Multistage pancreas biomimetic construct based on synergism of functionalized nanomedicines and cell differentiation
Co-supervisor of Joana Beatriz Antunes Moreira Carvalho Marques
|
Ciências Farmacêuticas (PhD)
Universidade do Porto Faculdade de Farmácia, Portugal
|
2014/09/01 - 2016/01/05 | Biomembranes as barrier for therapeutic entities
Co-supervisor of Melissa Sirage
|
M.Sc. in Biomedical Engineering (Master)
Universidade de Lisboa Faculdade de Ciências, Portugal
|
2015 - 2015 | Multicomponent Particulates for Immune Modulation
Supervisor of João Miguel de Oliveira Conniot
|
Farmácia (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2013/09/01 - 2014/12/01 | Development of nanosystems for HIV vaccine delivery
Co-supervisor of Ana Isabel Matos
|
M.Sc. in Biochemistry (Master)
Universidade de Lisboa Faculdade de Ciências, Portugal
|
2014 - 2014 | Development of a Melanoma Therapeutic Vaccine Candidate by the Coencapsulation of Melanoma Antigen Peptides and Toll-like
Receptor Ligands as Adjuvants into Polymeric Nanoparticles
Supervisor of Joana Catarina Mendão Azeitão da Silva
|
Farmácia (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2014 - 2014 | Intracellularly-targeted nanoplatform to target dendritic cells and for immunomodulation
Supervisor of Carina Sofia Gonçalves Peres
|
Farmácia (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2014 - 2014 | Anti-tumor immunity induced by a novel nanoparticulate vaccine: a mechanism approach
Supervisor of Eva Zupancic
|
Farmácia (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2014 - 2014 | Hybrid lipid-polymeric nanoplatform as cancer immunotherapeutics
Supervisor of Vanessa Gameiro Sainz
|
Farmácia (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2014 - 2014 | AKT2 siRNA-nanoparticulate system as a new tool to restoration of E-cadherin and eradicate tumour metastic phenotype
Co-supervisor of Diana Fernandes de Sousa Rafael
|
Farmácia (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
Committee member
Activity description Role |
Institution / Organization | |
---|---|---|
2023/08/28 - Current | Scientific council member
Member
|
Universidade de Lisboa Faculdade de Farmácia, Portugal |
2020/02/01 - Current | Executive Board Member
Member
|
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal |
2020/02/01 - Current | Executive Board Member
Member
|
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal |
Conference scientific committee
Conference name | Conference host | |
---|---|---|
2021/10/15 - 2021/10/15 | Cutaneous Melanoma: from where to where? | Liga Portuguesa COntra o Cancro |
Evaluation committee
Activity description Role |
Institution / Organization | Funding entity | |
---|---|---|---|
2016/12/01 - Current | Clinical Expert (Pharmacokinetics and Biodistribution) involved in the evalauation of Common Technical Documents related to
the approval of Medicines
Evaluator
|
Infarmed Autoridade Nacional do Medicamento e Produtos de Saúde IP |
Interview (newspaper / magazine)
Activity description | Newspaper / Forum | |
---|---|---|
2021/02/03 | Interview regarding the developmento fo a COVID-19 vaccine | Público newspaper |
2020/09/21 | Interview to Jornal Observador related to the COVID-19 project awarded by La CAixa FOundation | |
2019/08/06 | News regarding the publication of the Nature Nanotechnology paper on the development of our cancer nano-vaccine against melanoma | |
2019/08/06 | On the RTP journal news on the development of our cancer nano-vaccine, following the publication of our results on Nature Nanotechnology paper | RTP News national journal (afternoon and night emission) |
2019/08/06 | Several news published worldwide regarding our nano-vaccine against melanoma | Several news in several countries: israel, USA etc.. |
Interview (tv / radio show)
Program | Topic | |
---|---|---|
2021/02/24 - Current | The Old Friends - Antena 1 | COVID-19 |
2020/04/28 - Current | Programa Sociedade Civil -RTP2 | Cancer nanovaccine research to fight melanoma |
2019/08/06 - Current | News emission on TVI national agency - News on the development of our cancer nano-vaccine, following the publication of our results on Nature Nanotechnology paper | Cancer Vaccine against melanoma |
2019/08/05 - Current | RTP 3 | Nanovaccine against melanoma |
2019/08/05 - Current | News on the development of our cancer nano-vaccine, following the publication of our results on Nature Nanotechnology paper | RTP |
Distinctions
Award
2020 | Young Investigator Immunology
Controlled Release Society - Nanomedicine and Nanoscale Delivery Focus Group , United States
|
2015 | Gene therapy for HIV cure: two complementary strategies delivered by self-amplifying RNA vectors |
2014 | COMBI-VIH: multivalent nanoplatform for immunomodulation to control HIV infection.
Gilead Program Award , Portugal
|
Other distinction
2019 | Scientific achievements featured in the national and international press
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2015 | Young Scientist Award for the best oral communication award |
2015 | Best Poster award |
2013 | Best poster award |
2013 | Best oral communication |
2013 | Best poster award |
2011 | Best Oral commmunication award |
2009 | Grant awarded to participate in the “2nd ESF/UB European Summer School on Nanomedicine”, Lisboa, Portugal (2009). |
2007 | Research activity mentioned in the international press: McCluskey, M (2007). New vaccine technology. Equus Magazine, 352 (January): 10. |
2006 | Best Oral commmunication award |
2005 | Nomination for Controlled Release Society's Outstanding Veterinary Paper Award |